PF-48503 |
RISPERIDONA Aurobindo 3 mg Tabletas recubiertas simples |
2018-04-24 |
|
Aurobindo Pharma Limited. |
India
|
Seven Pharma Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-48504 |
CLARITROMICINA Astrazeneca 500 mg Tabletas recubiertas simples |
2018-04-26 |
|
AstraZeneca Camcar, S. A. |
India
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-48517 |
CIPROFLOXACINA Aurobindo 750 mg Tabletas recubiertas simples |
2018-05-02 |
|
Aurobindo Pharma Limited. |
India
|
Jogral Farmacéutica |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-48625 |
KOACT 156.25 Polvo para suspensión oral |
2028-09-04 |
|
Aurobindo Pharma Limited. |
India
|
Corporación Umed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-49577 |
TENOFOVIR DISOPROXIL FUMARATO Y EMTRICITABINA Aurobindo Pharma 300/200 mg tabletas recubiertas simples. |
2024-01-24 |
|
Aurobindo Pharma Limited. |
India
|
Comercializadora De Productos Farmacológicos |
Imcorsa |
Medicamentos Avanzados, Sociedad Anónima |
Soluciones Médicas De C.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-50185 |
TENOFOVIR DISOPROXIL FUMARATO Aurobindo 300 mg Tabletas recubiertas simples |
2019-06-19 |
|
Aurobindo Pharma Limited. |
India
|
Comercializadora De Productos Farmacológicos |
Imcorsa |
Medicamentos Avanzados, Sociedad Anónima |
Soluciones Médicas De C.A. |
Bawell Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-27461 |
CLARITROMICINA Aurobindo 500 mg. tabletas. |
2007-04-10 |
|
Aurobindo Pharma Limited. |
India
|
Cdi, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-27541 |
CIPROFLOXACINA Aurobindo 500 mg. Tabletas |
2007-05-13 |
|
Aurobindo Pharma Limited. |
India
|
Cdi, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-27717 |
INDINAVIR Aurobindo Pharma 400mg. capsulas. |
2007-05-27 |
|
Aurobindo Pharma Limited. |
India
|
Cdi, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-27718 |
DIDANOSINA Aurobindo Pharma 100mg. Tabletas amortiguadas masticables. |
2007-05-27 |
|
Aurobindo Pharma Limited. |
India
|
Cdi, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|